New radioactive therapy aims to control advanced prostate cancer
Disease control
Ongoing
This early-stage study tests a radioactive drug called 225Ac-PSMA-617 in men with PSMA-positive prostate cancer that has stopped responding to hormone therapy. The goal is to find a safe dose and see if it can help control the cancer, even in men who have already received a simil…
Phase: PHASE1 • Sponsor: Endocyte • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC